Erratum to: Efficacy of rasagiline and selegiline in Parkinson’s disease: a head-to-head 3-year retrospective case–control study (J Neurol, (2017), 264, (1254-1263), 10.1007/s00415-017-8523-y)

1Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The article “Efficacy of rasagiline and selegiline in Parkinson’s disease: a head-to-head 3-year retrospective case–control study”, written by Emanuele Cereda, Roberto Cilia, Margherita Canesi, Silvana Tesei, Claudio Bruno Mariani, Anna Lena Zecchinelli and Gianni Pezzoli, was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 26 May 2017 without open access. The original article was corrected. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 23 August 2017 to © The Author(s) 2017 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/ by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Cite

CITATION STYLE

APA

Cereda, E., Cilia, R., Canesi, M., Tesei, S., Mariani, C. B., Zecchinelli, A. L., & Pezzoli, G. (2017, September 1). Erratum to: Efficacy of rasagiline and selegiline in Parkinson’s disease: a head-to-head 3-year retrospective case–control study (J Neurol, (2017), 264, (1254-1263), 10.1007/s00415-017-8523-y). Journal of Neurology. Dr. Dietrich Steinkopff Verlag GmbH and Co. KG. https://doi.org/10.1007/s00415-017-8585-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free